OCEA
Ocean Biomedical, Inc.
$0.000300
0.00%
No data for this timeframe.
Vol
Inst. Holders5 funds
Inst. Value$64.6K
Inst. Activity0 buys / 2 sells
Recent Activity
Inst.
VANGUARD GROUP INC — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 31, 2023 | Taglich Brothers | INITIATE | Speculative Buy |
| Apr 27, 2023 | EF Hutton | MAINTAIN | Buy |
| Apr 13, 2023 | EF Hutton | REITERATE | Buy |
| Mar 16, 2023 | Fundamental Research Corp. | INITIATE | Buy |
| Mar 13, 2023 | EF Hutton | INITIATE | Buy |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $28.3K | DOUBLED |
| VANGUARD GROUP INC | $22.0K | EXIT |
| UBS Group AG | $13.3K | EXIT |
| TWO SIGMA INVESTMENTS, LP | $1.1K | — |
| BANK OF AMERICA CORP | $5.00 | — |
5 institutional holders with $64.6K total value (1,196,749 shares) as of 2025-Q1. Top holders: CITADEL, VANGUARD, UBS. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 523,998 | $28.3K | 43.8% | DOUBLED +1115.9% |
| 2 | VANGUARD GROUP INC | 406,529 | $22.0K | 34.0% | EXIT -100.0% |
| 3 | UBS Group AG | 246,259 | $13.3K | 20.6% | EXIT -100.0% |
| 4 | TWO SIGMA INVESTMENTS, LP | 19,871 | $1.1K | 1.7% | — |
| 5 | BANK OF AMERICA CORP /DE/ | 92 | $5.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | EXIT | 406,529 | 0 | -100.0% | $0.00 | 2025-Q2 |
| UBS Group AG | EXIT | 246,259 | 0 | -100.0% | $0.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | DOUBLED | 43,095 | 523,998 | +1115.9% | $28.3K | 2025-Q1 |
| UBS Group AG | DOUBLED | 55,147 | 246,259 | +346.6% | $13.3K | 2025-Q1 |
| UBS Group AG | DOUBLED | 152 | 55,147 | +36180.9% | $30.5K | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 104,408 | 43,095 | -58.7% | $23.8K | 2024-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 16,280 | 399 | -97.5% | $391.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action May 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2024-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 31, 2023 | Taglich Brothers | INITIATE | — | Speculative Buy |
| Apr 27, 2023 | EF Hutton | MAINTAIN | — | Buy |
| Apr 13, 2023 | EF Hutton | REITERATE | — | Buy |
| Mar 16, 2023 | Fundamental Research Corp. | INITIATE | — | Buy |
| Mar 13, 2023 | EF Hutton | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jun 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.